Member Info for researcher1

If the CEO is 'incredibly frustrated' as we have been hearing, then surely that means a) it is not particularly bad news, and b) neither is it amazing takeover-type news. Somewhere in-between lies 'solid' news, which for those results surely should mean a SP well North of £1. Very intriguing.

as posted in another thread, this looks like a company valuation issue - now why would that be important?

it feels like something else is afoot - they declare it is not a cash issue, so it must be an issue of company valuation, hardly important to prelims. Now why might that be important..?? hmm

yawn - damp squib indeed - more waiting needed, but maybe a chance to pick up some cheap shares today?

yes GLA tomorrow - we all know it will be good, let's hope it is excellent!

I was thinking exactly the same thing Div (about the Pharma contract). It seemed rampish to mention it - imagine what AZ would do for our street cred!

me too - that's 50 X average volume - something big stirring....

very necessary at the moment - we know it is underpriced - it will need a few days for the word to catch on over on Nasdaq, and for the ticker to appear in all the right places...

just passed the average at 4pm, so not exactly wild enthusiasm!

big smoke, I was certainly not suggesting a sell on the spike (I plan not to top slice until May), but just to look out for an 'expectation' spike - perhaps as jointhedots says, it will have to wait until tomorrow...

and that is at 1pm! - this could easily quadruple within a few days at this rate

volume beginning to build now, but wait for the spike....

if, as most of us on here believe, results will be strong tomorrow, and that therefore we feel the price has been deliberately manipulated, I would expect the real action/volume to begin around 3pm this afternoon. Let's see shall we?

some of it already back in. Can I control this baby on my own???

a bit of it was me, moving some into SBTX this morning - don't worry it will be back here soon!

we will have to see how the clinics do first - there's a strong likelihood that revenue will cover all running costs until Parsortix starts selling in large numbers, at which point no further funding will be needed.

despite my irritation with the terms of the raise and the exclusion of us p.i.s, it is great that it is out of the way, so that Nasdaq listing can have its full effect, without any funding concern. I will be watching carefully also on behalf of Angle and Opti, who are both considering listing there too.

yes Phantom I think we have been witnessing that since the SP passed 60, and the uptrend was confirmed. We know from AN already that the US investors who came in at 60p are in for a 10X return, so fingers are very sticky indeed.

there have been big buys consistently tom, I expect most will be iis, taking up the slack left by Jupiter. Clinics likely to be announced next week, I'd say, so perhaps this week will be seen as the last week of cheap shares.

let's all see how low we can get it (105?) over the next couple of days, and then buy millions ourselves at a discount to the directors....? just a thought, sticking up for the small investor...